Evidence map›Paper›PMID 18560533›Full record

ArticleEnvironmental health perspectives2008

Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor.

Shlomo Bakshi, Xiang Zhang, Sonia Godoy-Tundidor, Robert Yuk Sing Cheng, Maureen A Sartor, Mario Medvedovic, Shuk-Mei Ho

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shlomo BakshiDivision of Environmental Genetics and Molecular Toxicology, Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0056, USA.
Xiang Zhang
Sonia Godoy-Tundidor
Robert Yuk Sing Cheng
Maureen A Sartor
Mario Medvedovic
Shuk-Mei Ho
Center for Environmental Health · USCenter for Human Genetics · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
Epigenetic Basis for Prostate Carcinogenesis following Early Estrogenic ExposuresR01ES015584 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HO, SHUK-MEI, PRINS, GAIL S · 2008 to 2012
$3.1M
PROSTATIC DIFFERENTIATION &SEX HORMONE METABOLISMR01CA015776 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HO, SHUK-MEI · 1987 to 2008
$1.8M
Bayesian Mixture Modeling of Functional Genomics DataR01HG003749 · NHGRI · UNIVERSITY OF CINCINNATI · PI MEDVEDOVIC, MARIO · 2006 to 2009
$1.4M
Metallothionein &Cadmium Carcinogenesis in the ProstateR01CA062269 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HO, SHUK-MEI · 1995 to 2006
$1.4M
Hormone-induced inflammation and prostate cancerR01CA112532 · NCI · UNIVERSITY OF CINCINNATI · PI HO, SHUK-MEI · 2006 to 2009
$1.1M
Development Modulation of Mouse Uterine TumorigenesisR21ES013071 · NIEHS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HO, SHUK-MEI · 2004 to 2006
$462k
NCI NIH HHS CA112532NCI NIH HHS CA15776NCI NIH HHS CA62269NCI NIH HHS R01 CA015776NCI NIH HHS R01 CA062269NCI NIH HHS R01 CA112532NHGRI NIH HHS HG003749NHGRI NIH HHS R01 HG003749NIEHS NIH HHS ES006096NIEHS NIH HHS ES013071NIEHS NIH HHS ES015584NIEHS NIH HHS P30 ES006096NIEHS NIH HHS R01 ES015584NIEHS NIH HHS R21 ES013071
6 · The paper itself

Abstract

backgroundCadmium is implicated in prostate carcinogenesis, but its oncogenic action remains unclear.

objectivesIn this study we aimed to decipher changes in cell growth and the transcriptome in an immortalized human normal prostate epithelial cell line (NPrEC) following exposure to low-dose Cd.

methodsSynchronized NPrEC cells were exposed to different doses of Cd and assayed for cell viability and cell-cycle progression. We investigated changes in transcriptome by global profiling and used Ingenuity Pathways Analysis software to develop propositions about functional connections among differentially expressed genes. A neutralizing antibody was used to negate the effect of Cd-induced up-regulation of tumor necrosis factor (TNF) in NPrEC cells.

resultsExposure of NPrEC to 2.5 microM Cd enhanced cell viability and accelerated cell-cycle progression. Global expression profiling identified 48 genes that exhibited >or= 1.5-fold changes in expression after 4, 8, 16, and 32 hr of Cd treatment. Pathway analyses inferred a functional connection among 35 of these genes in one major network, with TNF as the most prominent node. Fourteen of the 35 genes are related to TNF, and 11 exhibited an average of >2-fold changes in gene expression. Real-time reverse transcriptase-polymerase chain reaction confirmed the up-regulation of 7 of the 11 genes (ADAM8, EDN1, IL8, IL24, IL13RA2, COX2/PTGS2, and SERPINB2) and uncovered a 28-fold transient increase in TNF expression in Cd-treated NPrEC cells. A TNF-neutralizing antibody effectively blocked Cd-induced elevations in the expression of these genes.

conclusionsNoncytotoxic, low-dose Cd has growth-promoting effects on NPrEC cells and induces transient overexpression of TNF, leading to up-regulation of genes with oncogenic and immunomodulation functions.

Indexed as

AntibodiesCadmiumCell CycleCell LineCell SurvivalDose-Response Relationship, DrugEpithelial CellsGene Expression ProfilingHumansMaleOligonucleotide Array Sequence AnalysisProstateReverse Transcriptase Polymerase Chain ReactionTumor Necrosis Factor-alphaAntibodiesCadmiumTumor Necrosis Factor-alphacarcinogenesiscytokineglobal expression profilingheavy metalsimmune responseinflammationIngenuity Pathway Analysisknowledge-based analysisprostate cancer

Identifiers

PMID18560533
PMCPMC2430233
OpenAlexW2045515144

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.